Registration - NEWS AGENCY OF NIGERIA

Philip Daniel Yatai
Apr, Tue, 2025

CAC gives businesses 6 weeks ultimatum to comply with registration requirements

259 total views today

By Lucy Ogalue

The Corporate Affairs Commission (CAC) has given all businesses operating in Nigeria a six-week ultimatum to comply with the registration requirements of the Companies and Allied Matters Act (CAMA), 2020.

The Commission, in a circular issued on Tuesday in Abuja, said that after the ultimatum, it would take necessary action against erring offenders who fail to comply.

”This includes legal action, against any Company, Limited Liability Partnership, Limited Partnership or Business Name found operating without registration or under a name different from its registered identity.

“It is a criminal offence under Section 863 of CAMA to carry on business in Nigeria without proper registration, or to use a name or acronym other than that under which the entity is legally registered,” it said.

According to the statement, Section 729 of the Act mandates all registered entities to display their registered name and number outside every business location.

It said that this should also be displayed on all official publications, including letterheads, signage, marketing and publicity materials.

It also said that Section 862(1) of the Act imposed strict penalties on individuals who knowingly made false statements in any document required under the Act.

According to CAC, such offenders risk a two-year prison term and a daily fine for each day the infraction continues.

The commission therefore advised all business owners to take immediate steps to regularise their operations, stating that non-compliance would be met with swift enforcement actions. (NAN)

Edited by Bayo Sekoni

NAFDAC discontinues registration of Artemether/Lumefantrine

Lydia Beshel
Feb, Fri, 2025

Health

NAFDAC discontinues registration of Artemether/Lumefantrine

368 total views today

Oral suspension

NAFDAC

By Aderogba George

The National Agency for Food and Drug Administration and Control (NAFDAC) has discontinued the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.

The announcement was made in a public alert No. 01/2025, released on the agency’s website Thursday.

According to the alert, the decision was made due to the instability of the reconstituted formulations, which can lead to a loss of efficacy over time.

It said the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.

NAFDAC will no longer accept new applications, renewals, or variations for this product.

According to the alert, stability studies have shown that once reconstituted, the Artemether/Lumefantrine oral suspension becomes unstable, which can result in a loss of efficacy.

The agency said this could lead to worsening health conditions, increased risks of complications, treatment delays, or even death.

It said NAFDAC had directed all zonal directors and state coordinators to carry out surveillance activities and remove all locally manufactured and imported products from circulation.

The agency also advised importers, distributors, retailers, healthcare professionals, and caregivers to cease the importation, distribution, and sale of the product immediately.

It said healthcare professionals and consumers had been urged to report any suspected sale of these products, as well as any substandard or falsified medicines, to the nearest NAFDAC office.

The agency said the public could also report adverse events or side effects through the agency’s E-reporting platforms or via the Med-safety application available on Android and iOS.

NAFDAC added that this alert would be uploaded to the World Health Organisation’s (WHO) Global Surveillance and Monitoring System (GSMS). (NAN)

Edited by Abiemwense Moru